肽NRP-1配体的结构-活性关系研究和生物学特性评估:N-末端半胱氨酸重要性的研究。

IF 3.3 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Anna K. Puszko , Piotr Sosnowski , Olivier Hermine , Gérard Hopfgartner , Yves Lepelletier , Aleksandra Misicka
{"title":"肽NRP-1配体的结构-活性关系研究和生物学特性评估:N-末端半胱氨酸重要性的研究。","authors":"Anna K. Puszko ,&nbsp;Piotr Sosnowski ,&nbsp;Olivier Hermine ,&nbsp;Gérard Hopfgartner ,&nbsp;Yves Lepelletier ,&nbsp;Aleksandra Misicka","doi":"10.1016/j.bmc.2023.117482","DOIUrl":null,"url":null,"abstract":"<div><p>Neuropilin-1 (NRP-1) is a major co-receptor of vascular endothelial growth factor receptor-2 (VEGFR-2). It may also stimulate tumour growth and metastasis independently of VEGF-A<sub>165</sub>. These functions make VEGF-A<sub>165</sub>/NRP-1 complex formation and its inhibition of great interest, where NRP-1 is the target for which effective ligands are sought. Design of peptide-like inhibitors represent a strategy with great potential in the treatment of NRP-1-related disorders. Here, we present the synthesis, molecular modelling, structure-activity relationship studies as well as biological evaluation of peptides with the branched sequences H<sub>2</sub>N-X-Lys(<em>h</em>Arg)-Dab-Oic-Arg-OH and H<em><sub>2</sub></em>N-Lys(X-<em>h</em>Arg)-Dab-Oic-Arg-OH. Two of the designed peptides, in which Cys was inserted in X position, expressed high affinity (∼40 nM value) for NRP-1 and were resistant to enzymatic digestion in human serum. Moreover, peptide/NRP-1 complex promoted fast intracytoplasmic protein trafficking towards the plasma membrane in breast cancer cells. Our results suggest that these compounds might be good candidates for further development of VEGF-A<sub>165</sub>/NRP-1 inhibitors.</p></div>","PeriodicalId":255,"journal":{"name":"Bioorganic & Medicinal Chemistry","volume":"94 ","pages":"Article 117482"},"PeriodicalIF":3.3000,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0968089623003309/pdfft?md5=3cd1c97dc2ceefc37b22b0bab927ca12&pid=1-s2.0-S0968089623003309-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Structure-activity relationship studies and biological properties evaluation of peptidic NRP-1 ligands: Investigation of N-terminal cysteine importance\",\"authors\":\"Anna K. Puszko ,&nbsp;Piotr Sosnowski ,&nbsp;Olivier Hermine ,&nbsp;Gérard Hopfgartner ,&nbsp;Yves Lepelletier ,&nbsp;Aleksandra Misicka\",\"doi\":\"10.1016/j.bmc.2023.117482\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Neuropilin-1 (NRP-1) is a major co-receptor of vascular endothelial growth factor receptor-2 (VEGFR-2). It may also stimulate tumour growth and metastasis independently of VEGF-A<sub>165</sub>. These functions make VEGF-A<sub>165</sub>/NRP-1 complex formation and its inhibition of great interest, where NRP-1 is the target for which effective ligands are sought. Design of peptide-like inhibitors represent a strategy with great potential in the treatment of NRP-1-related disorders. Here, we present the synthesis, molecular modelling, structure-activity relationship studies as well as biological evaluation of peptides with the branched sequences H<sub>2</sub>N-X-Lys(<em>h</em>Arg)-Dab-Oic-Arg-OH and H<em><sub>2</sub></em>N-Lys(X-<em>h</em>Arg)-Dab-Oic-Arg-OH. Two of the designed peptides, in which Cys was inserted in X position, expressed high affinity (∼40 nM value) for NRP-1 and were resistant to enzymatic digestion in human serum. Moreover, peptide/NRP-1 complex promoted fast intracytoplasmic protein trafficking towards the plasma membrane in breast cancer cells. Our results suggest that these compounds might be good candidates for further development of VEGF-A<sub>165</sub>/NRP-1 inhibitors.</p></div>\",\"PeriodicalId\":255,\"journal\":{\"name\":\"Bioorganic & Medicinal Chemistry\",\"volume\":\"94 \",\"pages\":\"Article 117482\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2023-10-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0968089623003309/pdfft?md5=3cd1c97dc2ceefc37b22b0bab927ca12&pid=1-s2.0-S0968089623003309-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioorganic & Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0968089623003309\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic & Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0968089623003309","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

Neuropilin-1(NRP-1)是血管内皮生长因子受体-2(VEGFR-2)的主要共受体。它还可以独立于VEGF-A165刺激肿瘤生长和转移。这些功能使VEGF-A165/NRP-1复合物的形成及其抑制引起了极大的兴趣,其中NRP-1是寻求有效配体的靶标。肽样抑制剂的设计代表了一种在治疗NRP-1相关疾病方面具有巨大潜力的策略。在此,我们介绍了具有分支序列H2N-X-Lys(hArg)-Dab-Oic-Arg-OH和H2N-Lys(X-hArg。两种设计的肽,其中Cys插入X位,对NRP-1表达高亲和力(~40nM值),并对人类血清中的酶消化具有抗性。此外,肽/NRP-1复合物促进了癌症细胞胞浆内蛋白向质膜的快速运输。我们的结果表明,这些化合物可能是进一步开发VEGF-A165/NRP-1抑制剂的良好候选者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Structure-activity relationship studies and biological properties evaluation of peptidic NRP-1 ligands: Investigation of N-terminal cysteine importance

Structure-activity relationship studies and biological properties evaluation of peptidic NRP-1 ligands: Investigation of N-terminal cysteine importance

Neuropilin-1 (NRP-1) is a major co-receptor of vascular endothelial growth factor receptor-2 (VEGFR-2). It may also stimulate tumour growth and metastasis independently of VEGF-A165. These functions make VEGF-A165/NRP-1 complex formation and its inhibition of great interest, where NRP-1 is the target for which effective ligands are sought. Design of peptide-like inhibitors represent a strategy with great potential in the treatment of NRP-1-related disorders. Here, we present the synthesis, molecular modelling, structure-activity relationship studies as well as biological evaluation of peptides with the branched sequences H2N-X-Lys(hArg)-Dab-Oic-Arg-OH and H2N-Lys(X-hArg)-Dab-Oic-Arg-OH. Two of the designed peptides, in which Cys was inserted in X position, expressed high affinity (∼40 nM value) for NRP-1 and were resistant to enzymatic digestion in human serum. Moreover, peptide/NRP-1 complex promoted fast intracytoplasmic protein trafficking towards the plasma membrane in breast cancer cells. Our results suggest that these compounds might be good candidates for further development of VEGF-A165/NRP-1 inhibitors.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Bioorganic & Medicinal Chemistry
Bioorganic & Medicinal Chemistry 医学-生化与分子生物学
CiteScore
6.80
自引率
2.90%
发文量
413
审稿时长
17 days
期刊介绍: Bioorganic & Medicinal Chemistry provides an international forum for the publication of full original research papers and critical reviews on molecular interactions in key biological targets such as receptors, channels, enzymes, nucleotides, lipids and saccharides. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. A special feature will be that colour illustrations will be reproduced at no charge to the author, provided that the Editor agrees that colour is essential to the information content of the illustration in question.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信